6PS4
XFEL beta2 AR structure by ligand exchange from Timolol to ICI-118551.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | FREE ELECTRON LASER |
Source details | SLAC LCLS BEAMLINE CXI |
Synchrotron site | SLAC LCLS |
Beamline | CXI |
Temperature [K] | 293 |
Detector technology | PIXEL |
Collection date | 2014-11-05 |
Detector | CS-PAD CXI-1 |
Wavelength(s) | 1.33 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 41.500, 76.200, 171.620 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.360 - 2.600 |
R-factor | 0.206 |
Rwork | 0.204 |
R-free | 0.24300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3d4s |
RMSD bond length | 0.009 |
RMSD bond angle | 0.990 |
Data reduction software | CrystFEL |
Data scaling software | CrystFEL |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 37.360 | 2.760 |
High resolution limit [Å] | 2.600 | 2.600 |
Number of reflections | 17521 | 2801 |
<I/σ(I)> | 4.7 | |
Completeness [%] | 100.0 | |
Redundancy | 338.5 | |
CC(1/2) | 0.990 | 0.250 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | LIPIDIC CUBIC PHASE | 293 | 0.1 M HEPES pH 7.0, 0.1 M Ammonium Sulfate, 30% PEG 400, 2 mM of target ligand ICI-118551 |